Genetic analysis of quantitative phenotypes in AD and MCI: Imaging, cognition and biomarkers

Brain Imaging and Behavior

Volumn 8, Issue 2, 2014, Pages 183-207

  Shen, Li ^a   Thompson, Paul M ^b   Potkin, Steven G ^c   Bertram, Lars ^d   Farrer, Lindsay A ^e   Foroud, Tatiana M ^a   Green, Robert C ^f   Hu, Xiaolan ^g   Huentelman, Matthew J ^h   Kim, Sungeun ^a   Kauwe, John S K ⁱ   Li, Qingqin ^j   Liu, Enchi ^k   Macciardi, Fabio ^c,l   Moore, Jason H ^m   Munsie, Leanne ⁿ   Nho, Kwangsik ^a   Ramanan, Vijay K ^a   Risacher, Shannon L ^a   Stone, David J ^o   Swaminathan, Shanker ^a   Toga, Arthur W ^b   Weiner, Michael W ^p   Saykin, Andrew J ^a   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Bristol Myers Squib Clinical Sample Strategy and Operations   (United States)

^h TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

ⁱ BRIGHAM YOUNG UNIVERSITY   (United States)

^j JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^k JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^l UNIVERSITY OF MILAN   (Italy)

^m DARTMOUTH MEDICAL SCHOOL   (United States)

ⁿ ELI LILLY AND COMPANY   (United States)

^o MERCK RESEARCH LABORATORIES   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Alzheimer's disease; Biomarker; Cognition; Genetic association study; Neuroimaging; Quantitative traits

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN E; BIOLOGICAL MARKER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ALZHEIMER DISEASE; APOLIPOPROTEIN C1 GENE; APOLIPOPROTEIN E GENE; ARTICLE; BIN1 GENE; CLINICAL TRIAL (TOPIC); CLU GENE; COGNITION; COPY NUMBER VARIATION; CR1 GENE; ENDOPHENOTYPE; FRMD6 GENE; FTO GENE; FUNCTIONAL NEUROIMAGING; GENE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAGI2 GENE; META ANALYSIS (TOPIC); MILD COGNITIVE IMPAIRMENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B GENE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL (TOPIC); PICALM GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; STRUCTURAL NEUROIMAGING; SYSTEMATIC REVIEW; TOMM40 GENE; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION; HUMANS; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PHENOTYPE;

EID: 84899809381     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9262-z     Document Type: Article

References (163)

1. Alexopoulos, P., Guo, L. H., Kratzer, M., Westerteicher, C., Kurz, A., & Perneczky, R. (2011). Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers. Dementia and Geriatric Cognitive Disorders, 32(3), 164-170.
2. Andrawis, J. P., Hwang, K. S., Green, A. E., Kotlerman, J., Elashoff, D., Morra, J. H., et al. (2012). Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiology of Aging, 33(5), 856-866.
3. Antunez, C., Boada, M., Gonzalez-Perez, A., Gayan, J., Ramirez-Lorca, R., Marin, J., et al. (2011a). The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. Genome Medicine, 3(5), 33.
4. Antunez, C., Boada, M., Lopez-Arrieta, J., Moreno-Rey, C., Hernandez, I., Marin, J., et al. (2011b). Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimers Dement, 7(4), e124-e129.
5. Apostolova, L. G., Hwang, K. S., Andrawis, J. P., Green, A. E., Babakchanian, S., Morra, J. H., et al. (2010). 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging, 31(8), 1284-1303.
6. Baig, S., Joseph, S. A., Tayler, H., Abraham, R., Owen, M. J., Williams, J., et al. (2010). Distribution and expression of picalm in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 69(10), 1071-1077.
7. Bakken, T. E., Dale, A. M., & Schork, N. J. (2011). A geographic cline of skull and brain morphology among individuals of European ancestry. Human Heredity, 72(1), 35-44.
8. Bakken, T. E., Roddey, J. C., Djurovic, S., Akshoomoff, N., Amaral, D. G., Bloss, C. S., et al. (2012). Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America, 109(10), 3985-3990.
9. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate-a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B: Methodological, 57(1), 289-300.
10. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics, 39(1), 17-23.
11. Biffi, A., Anderson, C. D., Desikan, R. S., Sabuncu, M., Cortellini, L., Schmansky, N., et al. (2010). Genetic variation and neuroimaging measures in Alzheimer disease. Archives of Neurology, 67(6), 677-685.
12. Bis, J. C., DeCarli, C., Smith, A. V., van der Lijn, F., Crivello, F., Fornage, M., et al. (2012). Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nature Genetics, 44(5), 545-551.
13. Bonner-Jackson, A., Okonkwo, O., & Tremont, G. (2012). Apolipoprotein E epsilon2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. The American Journal of Geriatric Psychiatry, 20(7), 584-593.
14. Brouwers, N., van Cauwenberghe, C., Engelborghs, S., Lambert, J. C., Bettens, K., Le Bastard, N., et al. (2012). Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Molecular Psychiatry, 17(2), 223-233.
15. Cantor, R. M., Lange, K., & Sinsheimer, J. S. (2010). Prioritizing GWAS results: a review of statistical methods and recommendations for their application. American Journal of Human Genetics, 86(1), 6-22.
16. Caroli, A., & Frisoni, G. B. (2010). The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiology of Aging, 31(8), 1263-1274.
17. Chen, H., & Sharp, B. M. (2004). Content-rich biological network constructed by mining PubMed abstracts. BMC Bioinformatics, 5, 147.
18. Chiang, M. C., Barysheva, M., McMahon, K. L., de Zubicaray, G. I., Johnson, K., Montgomery, G. W., et al. (2012). Gene network effects on brain microstructure and intellectual performance identified in 472 twins. Journal of Neuroscience, 32(25), 8732-8745.
19. Christoforou, A., Dondrup, M., Mattingsdal, M., Mattheisen, M., Giddaluru, S., Nothen, M. M., et al. (2012). Linkage-disequilibrium-based binning affects the interpretation of GWASs. American Journal of Human Genetics, 90(4), 727-733.
20. Collingridge, D. S. (2013). A primer on quantitized data analysis and permutation testing. Journal of Mixed Methods Research, 7(1), 81-97.
21. Crehan, H., Hardy, J., & Pocock, J. (2012). Microglia, Alzheimer's disease, and complement. International Journal of Alzheimer's Disease, 2012, 983640.
22. Cruchaga, C., Kauwe, J. S., Mayo, K., Spiegel, N., Bertelsen, S., Nowotny, P., et al. (2010). SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genetics, 6(9).
23. Cruchaga, C., Nowotny, P., Kauwe, J. S., Ridge, P. G., Mayo, K., Bertelsen, S., et al. (2011). Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Archives of Neurology, 68(8), 1013-1019.
24. Cruchaga, C., Kauwe, J. S., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., et al. (2012). Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Human Molecular Genetics, 21(20), 4558-4571.
25. Cruchaga, C., Kauwe, J. S., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., et al. (2013). GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron, 78(2), 256-268.
26. Damoiseaux, J. S., Seeley, W. W., Zhou, J., Shirer, W. R., Coppola, G., Karydas, A., et al. (2012). Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. Journal of Neuroscience, 32(24), 8254-8262.
27. David, R., Friedman, L., Mulin, E., Noda, A., Le Duff, F., Kennedy, Q., et al. (2011). Lack of association between COMT polymorphisms and apathy in Alzheimer's disease. Journal of Alzheimer's Disease, 27(1), 155-161.
28. De Jager, P. L., Shulman, J. M., Chibnik, L. B., Keenan, B. T., Raj, T., Wilson, R. S., et al. (2012). A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging, 33(5), 1017 e1011-1015.
29. Desikan, R. S., McEvoy, L. K., Holland, D., Thompson, W. K., Brewer, J. B., Aisen, P. S., et al. (2012). Apolipoprotein E {varepsilon}4 does not modulate amyloid-beta-associated neurodegeneration in preclinical Alzheimer disease. AJNR - American Journal of Neuroradiology. doi: 10. 3174/ajnr. A3267.
30. Dickerson, B. C., & Wolk, D. A. (2011). Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. Journal of Neurology, Neurosurgery and Psychiatry, 82(1), 45-51.
31. Evangelou, E., & Ioannidis, J. P. (2013). Meta-analysis methods for genome-wide association studies and beyond. Nature Reviews Genetics, 14(6), 379-389.
32. Fan, M., Liu, B., Zhou, Y., Zhen, X., Xu, C., & Jiang, T. (2010). Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neuroscience Letters, 479(3), 332-336.
33. Furney, S. J., Simmons, A., Breen, G., Pedroso, I., Lunnon, K., Proitsi, P., et al. (2011). Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Molecular Psychiatry, 16(11), 1130-1138.
34. Ge, T., Feng, J., Hibar, D. P., Thompson, P. M., & Nichols, T. E. (2012). Increasing power for voxel-wise genome-wide association studies: the random field theory, least square kernel machines and fast permutation procedures. NeuroImage, 63(2), 858-873.
35. Gombar, S., Jung, H. J., Dong, F., Calder, B., Atzmon, G., Barzilai, N., et al. (2012). Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics, 13, 353.
36. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). TREM2 variants in Alzheimer's disease. New England Journal of Medicine, 368(2), 117-127.
37. Han, M. R., Schellenberg, G. D., & Wang, L. S. (2010). Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study. BMC Neurology, 10, 90.
38. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41(10), 1088-1093.
39. Hibar, D. P., Kohannim, O., Stein, J. L., Chiang, M. C., & Thompson, P. M. (2011a). Multilocus genetic analysis of brain images. Frontiers in Genetics, 2, 73.
40. Hibar, D. P., Stein, J. L., Kohannim, O., Jahanshad, N., Jack, C. R., Weiner, M. W., et al. (2011b). Principal components regression: Multivariate, gene-based tests in imaging genomics. Biomedical Imaging: From Nano to Macro, 2011 I. E. International Symposium on, 289-293.
41. Hibar, D. P., Stein, J. L., Kohannim, O., Jahanshad, N., Saykin, A. J., Shen, L., et al. (2011c). Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. NeuroImage, 56(4), 1875-1891.
42. Hibar, D. P., Stein, J. L., Ryles, A. B., Kohannim, O., Jahanshad, N., Medland, S. E., et al. (2012). Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects. Brain Imaging and Behavior. doi: 10. 1007/s11682-012-9199-7.
43. Hirschhorn, J. N. (2009). Genomewide association studies-illuminating biologic pathways. New England Journal of Medicine, 360(17), 1699-1701.
44. Ho, A. J., Stein, J. L., Hua, X., Lee, S., Hibar, D. P., Leow, A. D., et al. (2010). A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proceedings of the National Academy of Sciences of the United States of America, 107(18), 8404-8409.
45. Hochberg, Y., & Tamhane, A. C. (1987). Multiple comparison procedures. New York: Wiley.
46. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J. C., Carrasquillo, M. M., et al. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics, 43(5), 429-435.
47. Holmans, P., Green, E. K., Pahwa, J. S., Ferreira, M. A., Purcell, S. M., Sklar, P., et al. (2009). Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. American Journal of Human Genetics, 85(1), 13-24.
48. Holton, P., Ryten, M., Nalls, M., Trabzuni, D., Weale, M. E., Hernandez, D., et al. (2013). Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk loci. Annals of Human Genetics, 77(2), 85-105.
49. Hong, M. G., Reynolds, C. A., Feldman, A. L., Kallin, M., Lambert, J. C., Amouyel, P., et al. (2012). Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease. Human Mutation, 33(3), 521-529.
50. Hu, X., Pickering, E., Liu, Y. C., Hall, S., Fournier, H., Katz, E., et al. (2011a). Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS ONE, 6(2), e16616.
51. Hu, X., Pickering, E. H., Hall, S. K., Naik, S., Liu, Y. C., Soares, H., et al. (2011b). Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment. Translational Psychiatry, 1, e54.
52. Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., et al. (2012). Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology, 79(9), 897-905.
53. Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Jr., Weiner, M. W., et al. (2010). Sex and age differences in atrophic rates: an ADNI study with n = 1368 MRI scans. Neurobiology of Aging, 31(8), 1463-1480.
54. Jack, C. R., Jr., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Lowe, V., et al. (2012). Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Archives of Neurology, 69(7), 856-867.
55. Jacobson, A. C., & Weis, J. H. (2008). Comparative functional evolution of human and mouse CR1 and CR2. Journal of Immunology, 181(5), 2953-2959.
56. Jagust, W. J., & Landau, S. M. (2012). Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging. Journal of Neuroscience, 32(50), 18227-18233.
57. Jahanshad, N., Nir, T., Jack, C. R., Jr., Weiner, M. W., Toga, A. W., & Thompson, P. M. (2012). Boosting power to associate brain connectivity measures and dementia severity using Seemingly Unrelated Regression. MICCAI NIBAD, 95-104.
58. Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., et al. (2012a). A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature, 488(7409), 96-99.
59. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2012b). Variant of TREM2 associated with the risk of Alzheimer's disease. New England Journal of Medicine.
60. Jun, G., Naj, A. C., Beecham, G. W., Wang, L. S., Buros, J., Gallins, P. J., et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology, 67(12), 1473-1484.
61. Jun, G., Vardarajan, B. N., Buros, J., Yu, C. E., Hawk, M. V., Dombroski, B. A., et al. (2012). Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Archives of Neurology, 69(10), 1270-1279.
62. Kamboh, M. I., Barmada, M. M., Demirci, F. Y., Minster, R. L., Carrasquillo, M. M., & Pankratz, V. S. (2011). Genome-wide association analysis of age-at-onset in Alzheimer's disease. Molecular Psychiatry. doi: 10. 1038/mp. 2011. 135.
63. Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., et al. (2012). Genome-wide association study of Alzheimer's disease. Translational Psychiatry, 2, e117.
64. Kauwe, J. S., Bertelsen, S., Mayo, K., Cruchaga, C., Abraham, R., Hollingworth, P., et al. (2010a). Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(4), 955-959.
65. Kauwe, J. S., Cruchaga, C., Bertelsen, S., Mayo, K., Latu, W., Nowotny, P., et al. (2010b). Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels. Journal of Alzheimer's Disease, 21(3), 833-842.
66. Kauwe, J. S., Cruchaga, C., Karch, C. M., Sadler, B., Lee, M., Mayo, K., et al. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS ONE, 6(2), e15918.
67. Keenan, B. T., Shulman, J. M., Chibnik, L. B., Raj, T., Tran, D., Sabuncu, M. R., et al. (2012). A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline. Human Molecular Genetics, 21(10), 2377-2388.
68. Kiddle, S. J., Thambisetty, M., Simmons, A., Riddoch-Contreras, J., Hye, A., Westman, E., et al. (2012). Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS ONE, 7(9), e44260.
69. Kim, S., Swaminathan, S., Shen, L., Risacher, S. L., Nho, K., Foroud, T., et al. (2011). Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology, 76(1), 69-79.
70. Kohannim, O., Hibar, D. P., Stein, J. L., Jahanshad, N., Jack, C. R., Weiner, M. W., et al. (2011). Boosting power to detect genetic associations in imaging using multi-locus, genome-wide scans and ridge regression. Paper presented at the Biomedical Imaging: From Nano to Macro, 2011 I. E. International Symposium on.
71. Kohannim, O., Hibar, D. P., Jahanshad, N., Stein, J. L., Hua, X., Toga, A. W., et al. (2012a). Predicting Temporal Lobe Volume on Mri from Genotypes Using L(1)-L(2) Regularized Regression. Proc IEEE Int Symp Biomed Imaging, 1160-1163.
72. Kohannim, O., Hibar, D. P., Stein, J. L., Jahanshad, N., Hua, X., Rajagopalan, P., et al. (2012b). Discovery and replication of gene influences on brain structure using LASSO regression. Frontiers in Neuroscience, 6, 115.
73. Lakatos, A., Derbeneva, O., Younes, D., Keator, D., Bakken, T., Lvova, M., et al. (2010). Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiology of Aging, 31(8), 1355-1363.
74. Langbaum, J. B., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., et al. (2009). Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage, 45(4), 1107-1116.
75. Liu, G., Jiang, Y., Wang, P., Feng, R., Jiang, N., Chen, X., et al. (2012). Cell adhesion molecules contribute to Alzheimer's disease: multiple pathway analyses of two genome-wide association studies. Journal of Neurochemistry, 120(1), 190-198.
76. Lourdusamy, A., Newhouse, S., Lunnon, K., Proitsi, P., Powell, J., Hodges, A., et al. (2012). Identification of cis-regulatory variation influencing protein abundance levels in human plasma. Human Molecular Genetics, 21(16), 3719-3726.
77. Luo, X. J., Li, M., Huang, L., Nho, K., Deng, M., Chen, Q., et al. (2012). The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors. PLoS ONE, 7(11), e50375.
78. Mackin, R. S., Insel, P., Tosun, D., Mueller, S. G., Schuff, N., Truran-Sacrey, D., et al. (2012). The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. American Journal of Geriatric Psychiatry.
79. Martinez-Mir, A., Gonzalez-Perez, A., Gayan, J., Antunez, C., Marin, J., Boada, M., et al. (2013). Genetic study of neurexin and neuroligin genes in Alzheimer's disease. Journal of Alzheimer's Disease, 35(2), 403-412.
80. Mattila, J., Koikkalainen, J., Virkki, A., van Gils, M., & Lotjonen, J. (2012). Design and application of a generic clinical decision support system for multiscale data. IEEE Transactions on Biomedical Engineering, 59(1), 234-240.
81. Meda, S. A., Koran, M. E., Pryweller, J. R., Vega, J. N., & Thornton-Wells, T. A. (2012a). Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging. doi: 10. 1016/j. neurobiolaging. 2012. 09. 020.
82. Meda, S. A., Narayanan, B., Liu, J., Perrone-Bizzozero, N. I., Stevens, M. C., Calhoun, V. D., et al. (2012b). A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. NeuroImage, 60(3), 1608-1621.
83. Melville, S. A., Buros, J., Parrado, A. R., Vardarajan, B., Logue, M. W., Shen, L., et al. (2012). Multiple loci influencing hippocampal degeneration identified by genome scan. Annals of Neurology, 72(1), 65-75.
84. Mukherjee, S., Kim, S., Gibbons, L. E., Nho, K., Risacher, S. L., Glymour, M. M., et al. (2012a). Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior, 6(4), 621-633.
85. Mukherjee, S., Trittschuh, E., Gibbons, L. E., Mackin, R. S., Saykin, A., & Crane, P. K. (2012b). Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI. Brain Imaging and Behavior, 6(4), 649-660.
86. Murphy, E. A., Roddey, J. C., McEvoy, L. K., Holland, D., Hagler, D. J., Jr., Dale, A. M., et al. (2012). CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging and Behavior, 6(1), 16-26.
87. Naj, A. C., Beecham, G. W., Martin, E. R., Gallins, P. J., Powell, E. H., Konidari, I., et al. (2010). Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genetics, 6(9).
88. Naj, A. C., Jun, G., Beecham, G. W., Wang, L. S., Vardarajan, B. N., Buros, J., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics, 43(5), 436-441.
89. Nam, D., Kim, J., Kim, S.-Y., & Kim, S. (2010). GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Research, 38(suppl 2), W749-W754.
90. Nho, K., Shen, L., Kim, S., Swaminathan, S., Risacher, S. L., & Saykin, A. J. (2011). The effect of reference panels and software tools on genotype imputation. AMIA Annual Symposium Proceedings, 2011, 1013-1018.
91. Nho, K., Corneveaux, J. J., Kim, S., Lin, H., Risacher, S. L., Shen, L., et al. (2013a). Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics. Molecular Psychiatry, 18(7), 739.
92. Nho, K., Corneveaux, J. J., Kim, S., Lin, H., Risacher, S. L., Shen, L., et al. (2013b). Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Molecular Psychiatry, 18(7), 781-787.
93. O'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., et al. (2011). A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS ONE, 6(12), e28092.
94. O'Dushlaine, C., Kenny, E., Heron, E. A., Segurado, R., Gill, M., Morris, D. W., et al. (2009). The SNP ratio test: pathway analysis of genome-wide association datasets. Bioinformatics, 25(20), 2762-2763.
95. Pan, Q., Hu, T., & Moore, J. H. (2013). Epistasis, complexity, and multifactor dimensionality reduction. Methods in Molecular Biology, 1019, 465-477.
96. Penrod, N. M., Cowper-Sal-lari, R., & Moore, J. H. (2011). Systems genetics for drug target discovery. Trends in Pharmacological Sciences, 32(10), 623-630.
97. Peterson, D., Munger, C., Crowley, J., Corcoran, C., Cruchaga, C., Goate, A. M., et al. (2013). Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. doi: 10. 1016/j. jalz. 2013. 02. 010.
98. Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., et al. (2009a). Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS ONE, 4(8), e6501.
99. Potkin, S. G., Turner, J. A., Brown, G. G., McCarthy, G., Greve, D. N., Glover, G. H., et al. (2009b). Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophrenia Bulletin, 35(1), 19-31.
100. Potkin, S. G., Turner, J. A., Fallon, J. A., Lakatos, A., Keator, D. B., Guffanti, G., et al. (2009c). Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Molecular Psychiatry, 14(4), 416-428.
101. Potkin, S. G., Turner, J. A., Guffanti, G., Lakatos, A., Fallon, J. H., Nguyen, D. D., et al. (2009d). A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophrenia Bulletin, 35(1), 96-108.
102. Potkin, S. G., Turner, J. A., Guffanti, G., Lakatos, A., Torri, F., Keator, D. B., et al. (2009e). Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cognitive Neuropsychiatry, 14(4-5), 391-418.
103. Purcell, S., Cherny, S. S., & Sham, P. C. (2003). Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics, 19(1), 149-150.
104. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81(3), 559-575.
105. Rajagopalan, P., Jahanshad, N., Stein, J. L., Kohannim, O., Hibar, D. P., Hua, X., et al. (2012). Commonly carried C677T risk variant in the folate pathway candidate gene, MTHFR, promotes brain deficits in the cognitively impaired elderly. Neuroimage: Clinical, 1, 179-187.
106. Ramanan, V. K., Kim, S., Holohan, K., Shen, L., Nho, K., Risacher, S. L., et al. (2012a). Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging and Behavior, 6(4), 634-648.
107. Ramanan, V. K., Shen, L., Moore, J. H., & Saykin, A. J. (2012b). Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends in Genetics, 28(7), 323-332.
108. Ramanan, V. K., Risacher, S. L., Nho, K., Kim, S., Swaminathan, S., Shen, L., et al. (2013). APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Molecular Psychiatry.
109. Raychaudhuri, S., Plenge, R. M., Rossin, E. J., Ng, A. C., Purcell, S. M., Sklar, P., et al. (2009). Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genetics, 5(6), e1000534.
110. Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., et al. (2007). GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron, 54(5), 713-720.
111. Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., et al. (2009). Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 106(16), 6820-6825.
112. Reitz, C., Tosto, G., Mayeux, R., & Luchsinger, J. A. (2012). Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. PLoS ONE, 7(12), e50354.
113. Rimol, L. M., Agartz, I., Djurovic, S., Brown, A. A., Roddey, J. C., Kähler, A. K., et al. (2010). Sex-dependent association of common variants of microcephaly genes with brain structure. Proceedings of the National Academy of Sciences, 107(1), 384-388.
114. Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., et al. (2010). Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiology of Aging, 31(8), 1401-1418.
115. Risacher, S. L., Kim, S., Shen, L., Nho, K., Foroud, T., Green, R. C., et al. (2013). The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Frontiers in Aging Neuroscience, 5, 11.
116. Roses, A. D., Lutz, M. W., Amrine-Madsen, H., Saunders, A. M., Crenshaw, D. G., Sundseth, S. S., et al. (2010). A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics Journal, 10(5), 375-384.
117. Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. Scientific World Journal, 2012, 756357.
118. Sabuncu, M. R., Buckner, R. L., Smoller, J. W., Lee, P. H., Fischl, B., & Sperling, R. A. (2012). The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cerebral Cortex, 22(11), 2653-2661.
119. Samtani, M. N., Farnum, M., Lobanov, V., Yang, E., Raghavan, N., Dibernardo, A., et al. (2012). An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative. Journal of Clinical Pharmacology, 52(5), 629-644.
120. Saykin, A. J., Shen, L., Foroud, T. M., Potkin, S. G., Swaminathan, S., Kim, S., et al. (2010). Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimer's and Dementia, 6(3), 265-273.
121. Saykin, A., Shen, L., Risacher, S., Swaminathan, S., Kim, S., Ngo, K., et al. (2012). Structural, functional and molecular imaging as intermediate phenotypes for studies of candidate genes, pathways and GWAS in Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 8(4), P232.
122. Schott, J. M. (2012). Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, 33(7), 1486 e1489-1415.
123. Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., et al. (2009). MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain, 132(Pt 4), 1067-1077.
124. Shen, L., Kim, S., Risacher, S. L., Nho, K., Swaminathan, S., West, J. D., et al. (2010). Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. NeuroImage, 53(3), 1051-1063.
125. Sherva, R., Tripodis, Y., Bennett, D. A., Chibnik, L. B., Crane, P. K., de Jager, P. L., et al. (2013). Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimer's & Dementia.
126. Silver, M., & Montana, G. (2012). Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Statistical Applications in Genetics and Molecular Biology, 11(1), Article 7.
127. Silver, M., Montana, G., & Nichols, T. E. (2011). False positives in neuroimaging genetics using voxel-based morphometry data. NeuroImage, 54(2), 992-1000.
128. Silver, M., Janousova, E., Hua, X., Thompson, P. M., & Montana, G. (2012b). Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression. NeuroImage, 63(3), 1681-1694.
129. Singh, N., Wang, A. Y., Sankaranarayanan, P., Fletcher, P. T., & Joshi, S. (2012). Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD. Medical Image Computing and Computer-Assisted Intervention, 15(Pt 1), 132-140.
130. Sloan, C. D., Shen, L., West, J. D., Wishart, H. A., Flashman, L. A., Rabin, L. A., et al. (2010). Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(5), 1060-1069.
131. Soares, H. D., Potter, W. Z., Pickering, E., Kuhn, M., Immermann, F. W., Shera, D. M., et al. (2012). Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Archives of Neurology, 1-8.
132. Spiegel, R., Berres, M., Miserez, A. R., & Monsch, A. U. (2011). For debate: substituting placebo controls in long-term Alzheimer's prevention trials. Alzheimer's Research & Therapy, 3(2), 9.
133. Stein, J. L., Hua, X., Lee, S., Ho, A. J., Leow, A. D., Toga, A. W., et al. (2010a). Voxelwise genome-wide association study (vGWAS). NeuroImage, 53(3), 1160-1174.
134. Stein, J. L., Hua, X., Morra, J. H., Lee, S., Hibar, D. P., Ho, A. J., et al. (2010b). Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. NeuroImage, 51(2), 542-554.
135. Stein, J. L., Hibar, D. P., Madsen, S. K., Khamis, M., McMahon, K. L., de Zubicaray, G. I., et al. (2011). Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N = 1198) using genome-wide search. Molecular Psychiatry, 16(9), 927-937, 881.
136. Stein, J. L., Medland, S. E., Vasquez, A. A., Hibar, D. P., Senstad, R. E., Winkler, A. M., et al. (2012). Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics, 44(5), 552-561.
137. Stone, D. J., Molony, C., Suver, C., Schadt, E. E., & Potter, W. Z. (2010). ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease. Pharmacogenomics Journal, 10(3), 161-164.
138. Swaminathan, S., Kim, S., Shen, L., Risacher, S. L., Foroud, T., Pankratz, N., et al. (2011). Genomic copy number analysis in Alzheimer's disease and mild cognitive impairment: an ADNI study. International Journal of Alzheimer's Disease, 2011, 729478.
139. Swaminathan, S., Huentelman, M. J., Corneveaux, J. J., Myers, A. J., Faber, K. M., Foroud, T., et al. (2012a). Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. PLoS ONE, 7(12), e50640.
140. Swaminathan, S., Shen, L., Kim, S., Inlow, M., West, J. D., Faber, K. M., et al. (2012b). Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. Current Alzheimer Research, 9(7), 801-814.
141. Swaminathan, S., Shen, L., Risacher, S. L., Yoder, K. K., West, J. D., Kim, S., et al. (2012c). Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging and Behavior, 6(1), 1-15.
142. Thambisetty, M., An, Y., Nalls, M., Sojkova, J., Swaminathan, S., Zhou, Y., et al. (2012). Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype. Biological Psychiatry. doi: 10. 1016/j. biopsych. 2012. 08. 015.
143. Tosun, D., Schuff, N., Truran-Sacrey, D., Shaw, L. M., Trojanowski, J. Q., Aisen, P., et al. (2010). Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiology of Aging, 31(8), 1340-1354.
144. Tosun, D., Schuff, N., Shaw, L. M., Trojanowski, J. Q., & Weiner, M. W. (2011). Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. Journal of Alzheimer's Disease, 26(Suppl 3), 77-90.
145. Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Shaw, L. M., Trojanowski, J. Q., et al. (2010). Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Annals of Neurology, 67(3), 308-316.
146. Vounou, M., Nichols, T. E., & Montana, G. (2010). Discovering genetic associations with high-dimensional neuroimaging phenotypes: a sparse reduced-rank regression approach. NeuroImage, 53(3), 1147-1159.
147. Vounou, M., Janousova, E., Wolz, R., Stein, J. L., Thompson, P. M., Rueckert, D., et al. (2012). Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease. NeuroImage, 60(1), 700-716.
148. Wan, J., Kim, S., Inlow, M., Nho, K., Swaminathan, S., Risacheri, S. L., et al. (2011). Hippocampal surface mapping of genetic risk factors in AD via sparse learning models. Medical Image Computing and Computer-Assisted Intervention, 14(Pt 2), 376-383.
149. Wang, K., Zhang, H., Kugathasan, S., Annese, V., Bradfield, J. P., Russell, R. K., et al. (2009). Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. American Journal of Human Genetics, 84(3), 399-405.
150. Wang, K., Li, M., & Hakonarson, H. (2010). Analysing biological pathways in genome-wide association studies. Nature Reviews Genetics, 11(12), 843-854.
151. Wang, H., Nie, F., Huang, H., Kim, S., Nho, K., Risacher, S. L., et al. (2012a). Identifying quantitative trait loci via group-sparse multitask regression and feature selection: an imaging genetics study of the ADNI cohort. Bioinformatics, 28(2), 229-237.
152. Wang, H., Nie, F., Huang, H., Risacher, S. L., Saykin, A. J., & Shen, L. (2012b). Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning. Bioinformatics, 28(12), i127-i136.
153. Wang, H., Nie, F., Huang, H., Yan, J., Kim, S., Nho, K., et al. (2012c). From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs. Bioinformatics, 28(18), i619-i625.
154. Wang, Z. Y., Fu, L. Y., & Zhang, H. Y. (2012d). Can medical genetics and evolutionary biology inspire drug target identification? Trends in Molecular Medicine, 18(2), 69-71.
155. Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., et al. (2012). The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement, 8(1 Suppl), S1-S68.
156. Wolk, D. A., & Dickerson, B. C. (2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 107(22), 10256-10261.
157. Wolz, R., Aljabar, P., Hajnal, J. V., Lotjonen, J., & Rueckert, D. (2012). Nonlinear dimensionality reduction combining MR imaging with non-imaging information. Medical Image Analysis, 16(4), 819-830.
158. Wyss-Coray, T., & Rogers, J. (2012). Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Perspectives in Medicine, 2(1), a006346.
159. Xiao, Q., Gil, S. C., Yan, P., Wang, Y., Han, S., Gonzales, E., et al. (2012). Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. Journal of Biological Chemistry, 287(25), 21279-21289.
160. Xu, C., Wang, Z., Fan, M., Liu, B., Song, M., Zhen, X., et al. (2010). Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease. Neuroreport, 21(12), 802-807.
161. Ye, J., Farnum, M., Yang, E., Verbeeck, R., Lobanov, V., Raghavan, N., et al. (2012). Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurology, 12, 46.
162. Yesavage, J. A., Noda, A., Hernandez, B., Friedman, L., Cheng, J. J., Tinklenberg, J. R., et al. (2011). Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease. The American Journal of Geriatric Psychiatry, 19(7), 635-643.
163. Yu, P., Dean, R. A., Hall, S. D., Qi, Y., Sethuraman, G., Willis, B. A., et al. (2012). Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia. Journal of Alzheimer's Disease, 32(2), 373-385.